Cardiovascular Disease Doctors in College Station, TX Accepting Medicare

7 Cardiovascular Disease doctors found. Showing 1 - 7

Dr. Thomas H. Meade, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1721 Birmingham Rd Ste 202, College Station, TX 77845 Phone: 979-446-0373

Mario A Lammoglia, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1721 Birmingham Dr, College Station, TX 77845 Phone: 979-764-1474    Fax: 979-764-9249

Dr. Srinath Vemuri, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Scott And White Dr, College Station, TX 77845 Phone: 979-207-4000    Fax: 979-207-4562

Dr. Curtis Clarence Stauffer, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Scott And White Dr, College Station, TX 77845 Phone: 979-207-4000    Fax: 979-207-4562

Dr. D. Brent Glamann, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1600 University Dr E, College Station, TX 77840 Phone: 409-691-3300

Charles Howard, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 800 Scott And White Dr, College Station, TX 77845 Phone: 979-207-4000

Dr. Daniel J. Larsen, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Scott And White Dr, College Station, TX 77845 Phone: 979-207-4000    Fax: 979-207-4562

News Archive

Aging population correlates with a switch from acute infectious diseases to chronic diseases as the major cause of morbidity and mortality

Some diseases like ulcers and certain types of cancer, once thought to be primarily related to lifestyle factors, are now known to be caused by microorganisms, and many more syndromes, including some psychiatric conditions, may have a connection to infection, according to a report released today by the American Academy of Microbiology.

MLL team finds 454 Sequencing technology promising for leukemia genetic characterization

This week at the 51st American Society for Hematology Annual Meeting, a team of researchers from the MLL Munich Leukemia Laboratory presented results from a series of groundbreaking studies which explore alternative, high-throughput 454 Sequencing methods for distinguishing and characterizing the many forms of leukemia and myeloproliferative disorders.

New Tel Aviv University study may pave way for personalized bipolar disorder treatment

Rapidly swinging from extremes of joy and energy to sadness, fatigue, and confusion, bipolar disorder (BD) patients feel desperate and largely alone in the world. And according to the National Institutes of Health, between 25-50 percent of the roughly 3% of Americans living with BD attempt suicide at least once.

Planet Green to be acquired by IMAGIN Molecular

IMAGIN Molecular Corporation (OTCBB: IMGM) has agreed in a letter of intent to issue 49% of the post capitalization of IMGM in exchange for 84,000,000 Positron Corporation common shares plus 100% of the equity of the Planet Green Bottle, all IMGM shares to be distributed to shareholders or affiliates of Planet Green.

FDA endorses Covidien's REMS program for EXALGO tablets

Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that it presented information to members of a U.S. Food and Drug Administration (FDA) Advisory Committee on the New Drug Application and proposed Risk Evaluation and Mitigation Strategy (REMS) program for EXALGOTM (hydromorphone HCl extended release) tablets, an opioid formulation.

Read more Medical News

› Verified 3 days ago